NT_1170x120_1-11-18

Roche Diagnostics

Nimble teams to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics

Nimble teams to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics

MADISON, Wis. — Nimble Therapeutics announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays. Nimble will extend its proprietary peptide synthesis, screening and optimization platform to enable faster discovery and optimization of promising compounds for detecting SARS-CoV-2. Roche will leverage its world-class

Roche to buy diabetes app provider mySugr

Roche to buy diabetes app provider mySugr

BASEL, Switzerland — Roche has entered an agreement to acquire mySugr GmbH, a Vienna-based provider of diabetes management apps and services. The drug maker said mySugr’s leading mobile diabetes platform, with more than 1 million users globally, will become a linchpin of its new patient-centered digital health services platform in diabetes care. Founded in 2012